Kingfisher PLC has announced the purchase of 25,000 ordinary shares for cancellation on 19 February 2026, as part of its £300 million share repurchase programme initiated on 25 March 2025. These shares were acquired from Goldman Sachs International at a volume-weighted average price of £3.6060, with individual transactions ranging from £3.5910 to £3.6370. This purchase brings the total shares repurchased in the fifth tranche of the programme to 18,938,200.
Kingfisher plc, ISIN: GB0033195214 (the "Company", "Kingfisher") announces that on 19 February 2026 it purchased for cancellation the following number of ordinary shares of 15 5/7 pence each from Goldman Sachs International ("GSI") as part of its £300 million share repurchase programme announced on 25 March 2025 (the "Programme"). All shares were purchased by Kingfisher from GSI as an "on-exchange" transaction subject to the rules of the London Stock Exchange.
Date of Purchase:
19 February 2026
Total number of shares purchased:
25,000
Volume Weighted Average price paid per share:
£3.6060
Highest price paid per share:
£3.6370
Lowest price paid per share:
£3.5910
To date, Kingfisher has purchased 18,938,200 ordinary shares in aggregate for cancellation from GSI in connection with the fifth tranche of the Programme. Kingfisher also previously purchased 17,932,871 ordinary shares in aggregate for cancellation from GSI,18,118,306 ordinary shares in aggregate for cancellation from BNP Paribas SA, 24,713,988 ordinary shares in aggregate for cancellation from GSI and 16,095,884 ordinary shares in aggregate for cancellation from Morgan Stanley & Co. International Plc in connection with its execution of the first, second, third and fourth tranches, respectively, of the Programme.
A schedule of individual trades carried out by GSI as principal in connection with the above purchases is set out below.
Schedule of Purchases - Aggregate Information
Trading Venue
Number of Shares
Volume Weighted Average Price paid per share
XLON
25,000
£3.6060
CHIX
0
£0.0000
BATE
0
£0.0000
TRQX
0
£0.0000
AQXE
0
£0.0000
Schedule of Purchases - Individual Transactions
Price GBP
Time of each trade on 19 Feb 2026 (GMT)
Trading Venue
Number of Shares
Transaction Reference Number
3.6300
08:39:24
XLON
940
1392901456140103
3.6280
08:39:34
XLON
1,019
1392901456140118
3.6370
08:54:22
XLON
220
1392901456141058
3.6370
08:54:22
XLON
706
1392901456141059
3.6360
09:14:25
XLON
952
1392901456142509
3.6210
09:46:52
XLON
1,005
1392901456144532
3.5960
10:10:33
XLON
1,009
1392901456146262
3.5960
10:52:48
XLON
982
1392901456149012
3.5920
11:06:22
XLON
1,031
1392901456149819
3.5990
11:36:58
XLON
928
1392901456151826
3.6030
12:13:05
XLON
924
1392901456154099
3.6010
12:37:24
XLON
313
1392901456155629
3.6010
12:37:24
XLON
630
1392901456155630
3.6040
13:19:09
XLON
941
1392901456158095
3.6010
13:34:35
XLON
145
1392901456158845
3.6030
13:36:15
XLON
922
1392901456158937
3.6130
14:10:47
XLON
1,089
1392901456161201
3.6090
14:18:38
XLON
936
1392901456161742
3.6090
14:32:51
XLON
839
1392901456164237
3.6090
14:32:51
XLON
107
1392901456164238
3.6040
14:44:13
XLON
1,069
1392901456167140
3.6030
14:56:06
XLON
976
1392901456170376
3.5950
15:07:42
XLON
979
1392901456173559
3.5960
15:21:27
XLON
581
1392901456176610
3.5960
15:21:27
XLON
487
1392901456176611
3.6050
15:36:50
XLON
927
1392901456179597
3.6010
15:52:36
XLON
1,057
1392901456182740
3.5910
16:04:42
XLON
973
1392901456185586
3.5930
16:17:34
XLON
993
1392901456188648
3.5940
16:24:38
XLON
1,320
1392901456191372
Contacts:
Tel:
Email:
Group Company Secretariat
+44 (0) 20 7372 8008
secretariat@kingfisher.com
Investor Relations
+44 (0) 20 7644 1082
investorenquiries@kingfisher.com
Treasury
+44 (0) 20 7372 8008
treasury@kingfisher.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
AI Summary Disclaimer BETA
The content you are viewing has been generated or assisted by artificial
intelligence (AI). While efforts are made to ensure accuracy and clarity, AI-generated text may
contain inaccuracies, outdated information, or subjective interpretations. This content is intended
for general informational purposes only and should not be considered professional advice or factual
confirmation.
We encourage you to independently verify any information provided,
especially if it will be relied upon for making decisions or taking action. Any reliance you place
on this material is strictly at your own risk. The AI system that produced this content cannot
assess the specifics of individual circumstances, and results may vary based on context and
individual needs.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.
Create an Account
Create your FREE account to receive personalised announcements, watchlists, market updates, investment insights and new features.
Personalise your experience
Tell us a little about yourself to receive personalised content, announcements and relevant investment opportunities.
